![Longitudinal characterization of phenotypic profile of T cells in chronic hepatitis B identifies immune markers associated with HBsAg loss - eBioMedicine Longitudinal characterization of phenotypic profile of T cells in chronic hepatitis B identifies immune markers associated with HBsAg loss - eBioMedicine](https://www.thelancet.com/cms/attachment/c7dee2c1-05cf-401f-93cd-390cb1206598/gr1_lrg.jpg)
Longitudinal characterization of phenotypic profile of T cells in chronic hepatitis B identifies immune markers associated with HBsAg loss - eBioMedicine
![Immunodominant MHC-II (Major Histocompatibility Complex II) Restricted Epitopes in Human Apolipoprotein B | Circulation Research Immunodominant MHC-II (Major Histocompatibility Complex II) Restricted Epitopes in Human Apolipoprotein B | Circulation Research](https://www.ahajournals.org/cms/asset/aaeb2292-737e-43af-a29d-9c6d7556154d/circresaha.122.321116.fig09.jpg)
Immunodominant MHC-II (Major Histocompatibility Complex II) Restricted Epitopes in Human Apolipoprotein B | Circulation Research
![Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry - Freudenmann - 2018 - Immunology - Wiley Online Library Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry - Freudenmann - 2018 - Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/04bdee40-bc61-4d23-b36c-13cd8220d591/imm12936-fig-0001-m.jpg)
Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry - Freudenmann - 2018 - Immunology - Wiley Online Library
![Expression of activation (CD38 and HLA-DR) and senescence (CD57 and... | Download Scientific Diagram Expression of activation (CD38 and HLA-DR) and senescence (CD57 and... | Download Scientific Diagram](https://www.researchgate.net/publication/49742362/figure/fig1/AS:202968864432134@1425402956239/Expression-of-activation-CD38-and-HLA-DR-and-senescence-CD57-and-CD28-markers-on-CD4.png)
Expression of activation (CD38 and HLA-DR) and senescence (CD57 and... | Download Scientific Diagram
![Human Leukocyte Antigen (HLA) Typing and Stem Cell Harvesting: Information for Donors | Memorial Sloan Kettering Cancer Center Human Leukocyte Antigen (HLA) Typing and Stem Cell Harvesting: Information for Donors | Memorial Sloan Kettering Cancer Center](https://www.mskcc.org/sites/default/files/patient_ed/human_leukocyte_antigen_hla_typing_and_stem_cell_collection_information_for_donors-129784/hla_markers-en.png)
Human Leukocyte Antigen (HLA) Typing and Stem Cell Harvesting: Information for Donors | Memorial Sloan Kettering Cancer Center
![Cancers | Free Full-Text | Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer Cancers | Free Full-Text | Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer](https://pub.mdpi-res.com/cancers/cancers-13-03841/article_deploy/html/images/cancers-13-03841-ag.png?1628043076)
Cancers | Free Full-Text | Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer
![Abrogation of HLA surface expression using CRISPR/Cas9 genome editing: a step toward universal T cell therapy | Scientific Reports Abrogation of HLA surface expression using CRISPR/Cas9 genome editing: a step toward universal T cell therapy | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-74772-9/MediaObjects/41598_2020_74772_Fig1_HTML.png)
Abrogation of HLA surface expression using CRISPR/Cas9 genome editing: a step toward universal T cell therapy | Scientific Reports
![Frontiers | HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers Frontiers | HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers](https://www.frontiersin.org/files/Articles/791535/fimmu-12-791535-HTML-r1/image_m/fimmu-12-791535-g001.jpg)